000 | 04156cam a2200445 i 4500 | ||
---|---|---|---|
001 | 1752991 | ||
003 | OSt | ||
005 | 20200603114756.0 | ||
008 | 190610t20192019sz a b 001 0 eng | ||
020 |
_a9783030007096 _qhardcover |
||
020 |
_a303000709X _qhardcover |
||
020 |
_z9783030007102 _qelectronic book |
||
035 | _a(OCoLC)1104139389 | ||
040 |
_aPCP _beng _erda _cPCP _dOCLCF _dNTU _dOHX _dYDXIT _dOCLCO _dMFS |
||
041 | 0 | 9 | _aeng |
042 | _apcc | ||
050 | 0 | 4 |
_aRS380 _b.P484 2019 |
060 | 0 | 0 | _a2019 F-565 |
060 | 1 | 0 | _aQV 778 |
082 | 0 | 4 |
_a615.1/9 _223 |
130 | 0 |
_aPharmaceutical biotechnology (Crommelin) _939974 |
|
245 | 1 | 0 |
_aPharmaceutical biotechnology : _bfundamentals and applications / _cDaan J.A. Crommelin, Robert D. Sindelar, Bernd Meibohm, editors. |
250 | _aFifth edition. | ||
264 | 1 |
_aCham, Switzerland : _bSpringer, _c[2019] |
|
264 | 4 | _c©2019 | |
300 |
_axxiii, 653 pages : _billustrations (chiefly color) ; _c29 cm |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aMolecular Biotechnology: From DNA Sequence to Therapeutic Protein / Ronald S. Oosting -- Biophysical and Biochemical Characteristics of Therapeutic Proteins / Wim Jiskoot and Daan J. A. Crommelin -- Protein Stability and Characterization / Atanas Koulov -- Production and Purification of Recombinant Proteins / Alfred Luitjens and Emile van Corven -- Formulation of Biologics Including Biopharmaceutical Considerations / Daan J. A. Crommelin, Andrea Hawe, and Wim Jiskoot -- Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins / Bernd Meibohm -- Immunogenicity of Therapeutic Proteins / Wim Jiskoot, Theo Rispens, and Grzegorz Kijanka -- Monoclonal Antibodies: From Structure to Therapeutic Application / Rong Deng, C. Andrew Boswell, Wendy S. Putnam, Meina T. Tang, Amit Garg, Chunze Li, Shan Chung, and Sandhya Girish -- Genomics, Other "OMIC" Technologies, Precision Medicine, and Additional Biotechnology-Related Techniques / Robert D. Sindelar -- Dispensing Biotechnology Products: Handling, Professional Education, and Product Information / Robert D. Sindelar -- Economic Considerations in Medical Biotechnology / Amit S. Patel and Kartick P. Shirur -- Regulatory Framework for Biosimilars / Vinod P. Shah and Daan J. A. Crommelin -- An Evidence-Based Practice Approach to Evaluating Biotechnologically Derived Medications / James P. McCormack -- Vaccines / Wim Jiskoot, Gideon F. A. Kersten, Enrico Mastrobattista, and Bram Slütter -- Oligonucleotides -- Raymond M. Schiffelers, Erik Oude Blenke, and Enrico Mastrobattista -- Gene Therapy / Hao Wu, Amit Kumar Chaudhary, and Ram I. Mahato -- Advanced Therapies: Clinical, Non-clinical and Quality Considerations/ Karin H. Hoogendoorn -- Insulin / John M. Beals, Michael R. DeFelippis, Chad D. Paavola, David P. Allen, Ashish Garg, and D. Bruce Baldwin -- Follicle-Stimulating Hormone / Tom Sam and Renato de Leeuw -- Human Growth Hormone / Le N. Dao, Barbara Lippe, Michael Laird, and Ingrid Beierle -- Recombinant Coagulation Factors and Thrombolytic Agents / Koen Mertens and Alexander B. Meijer -- Recombinant Human Deoxyribonuclease I / Robert A. Lazarus and Jeffrey S. Wagener† -- Monoclonal Antibodies in Cancer / Jürgen Barth -- Hematopoietic Growth Factors / Juan Jose Pérez-Ruixo -- Monoclonal Antibodies in Solid Organ Transplantation / Nicole A. Pilch, Holly B. Meadows, and Rita R. Alloway -- Antibody-Based Biotherapeutics in Inflammatory Diseases / Honghui Zhou, Yan Xu, and Amarnath Sharma -- Interferons and Interleukins / Jean-Charles Ryff and Sidney Pestka†. | |
546 | _aEnglish | ||
650 | 1 | 2 |
_aTechnology, Pharmaceutical _0https://id.nlm.nih.gov/mesh/D013678 _939975 |
700 | 1 |
_aCrommelin, D. J. A. _q(Daan J. A.), _eeditor. _939976 |
|
700 | 1 |
_aSindelar, Robert D., _eeditor. _939977 |
|
700 | 1 |
_aMeibohm, Bernd, _eeditor. _939978 |
|
856 |
_uhttps://online.fliphtml5.com/lluzx/iobt/ _zЦахимаар унших |
||
942 |
_2ddc _cEB |
||
999 |
_c17785 _d17785 |